3:首次持股聲明-股東 Sealbond Ltd
3:首次持股聲明-董事 Yu Ying Choi Alan Abel
3:首次持股聲明-董事 Toh Kean Meng Melvin
SC 13D:超過5%持股股東披露文件-Sealbond Limited(15.9%),CK Life Sciences Int’l., (Holdings) Inc.(15.9%)
Virios Therapeutics | 4:持股變動聲明-董事 Pridgen William
Virios Therapeutics | 4:持股變動聲明-董事 Thomas John C
Virios Therapeutics | 4:持股變動聲明-董事 Whitley Richard James
Virios Therapeutics | 4:持股變動聲明-董事 Keefer David R
Virios Therapeutics | 4:持股變動聲明-董事 Burch Richard Alan
Virios Therapeutics | 4:持股變動聲明-董事 De La Rosa Abel
Virios Therapeutics | 4:持股變動聲明-高管 Walsh Angela
Virios Therapeutics | 4:持股變動聲明-高管 Grosswald Ralph
Virios Therapeutics | 4:持股變動聲明-高管 Gendreau Roger Michael
Virios Therapeutics | 4:持股變動聲明-高管 Duncan Gregory Scott
Virios Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Brian Corday(4.6%)
Virios Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Brian Corday(6.84%)
Virios Therapeutics | 4:持股變動聲明-董事 Pridgen William
Virios Therapeutics | 4:持股變動聲明-首席執行官 Duncan Gregory Scott
Virios Therapeutics | 4:持股變動聲明-董事 Keefer David R
Virios Therapeutics | 4:持股變動聲明-董事 De La Rosa Abel
暫無數據
暫無數據